Abstract
Identification and development of new monoclonal antibodies and other biological molecules such ad Fab fragments, diabodies and peptides is a key focus of many biotechnology and pharmaceutical companies and academic research department in several therapeutic areas, including oncology, autoimmune disease and infection. Before commencing clinical trials with such products, it is often essential to assess the targeting and/or efficacy effects that are desirable for such biological molecules as well as the potential for off-target effects as a result of non-specific uptake. Here we describe some of the methods that may be used to investigate labeled proteins and similar biological molecules
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bolton AE, Hunter WM (1973) The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J 133:529–539
Deshpande SV, DeNardo SJ, Kukis DL, Moi MK, McCall MJ, DeNardo GL, Meares CF (1990) Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent. J Nucl Med 31:473–479
Dillman LT, Von der Lage FC (1975) Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation. Medical Internal Radiation Dose Pamphlet No10. Society of Nuclear Medicine, New York
Fraker PJ, Speck JC Jr (1978) Protein and cell membrane iodinations with a sparingly soluble chloramide, 1, 3, 4, 6-tetrachloro-3a, 6a-diphenylglycoluril. Biochem Biophys Res Commun 80:849–857
Hnatowich DJ, Childs RL, Lanteigne D, Najafi A (1983) The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method. J Immunol Methods 65:147–157
Loevinger R, Berman M (1968) A schema for absorbed-dose calculations for biologically- distributed radionuclides. Medical Internal Radiation Dose Pamphlet No 1. J Nucl Med 9(Suppl 1):8–14
Meares CF, McCall MJ, Reardan DT, Goodwin DA, Diamanti CI, McTigue M (1984) Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. Anal Biochem 142:68–78
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this protocol
Cite this protocol
Green, C., Djeha, H., Rowlinson-Busza, G., Kousparou, C., Epenetos, A.A. (2010). Xenograft Mouse Models for Tumour Targeting. In: Kontermann, R., Dübel, S. (eds) Antibody Engineering. Springer Protocols Handbooks. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01147-4_35
Download citation
DOI: https://doi.org/10.1007/978-3-642-01147-4_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01146-7
Online ISBN: 978-3-642-01147-4
eBook Packages: Springer Protocols